Boston Common Asset Management, LLC NOVOZYMES A/S Transaction History

Boston Common Asset Management, LLC

  • $1.7 Billion
  • Q4 2024
Number of Shares
17,101
Previous 19,825 13.74%
Holding current value
$0
Previous $1.43 Million 100.0%
% of portfolio
0.0%
Previous 0.04%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025
SELL
N/A
-2,724 Reduced 13.74%
17,101 $0
Q3 2024

Oct 09, 2024
SELL
N/A
-13,288 Reduced 40.13%
19,825 $1.43 Million
Q2 2024

Jul 08, 2024
SELL
N/A
-9,302 Reduced 21.93%
33,113 $2.03 Million
Q1 2024

Apr 11, 2024
SELL
N/A
-11,216 Reduced 20.91%
42,415 $2.49 Million
Q4 2023

Jan 09, 2024
SELL
N/A
-130,878 Reduced 70.93%
53,631 $2.95 Million
Q3 2023

Oct 11, 2023
SELL
N/A
-2,408 Reduced 1.29%
184,509 $7.46 Million
Q2 2023

Jul 24, 2023
SELL
N/A
-25 Reduced 0.01%
186,917 $8.71 Million
Q1 2023

May 17, 2023
BUY
N/A
186,942 New
186,942 $9.57 Million
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email